GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - China". The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape ..."
The report is concentrated on the implementation of China New Medical Reform Policy and its influence on China medicine industry. The report analyzes the forthcoming National Essential Medicine List 2012 and conducts a statistics work on provinces added list. Besides, it also had ..."
GBI Research, the leading business intelligence provider, has released its latest research "Pharmaceutical Pricing and Reimbursement in China - Series of Mandated Price Cuts Not Effective in Stemming Healthcare Expenditures". The report provides a comprehensive overview of the he ..."